We are exploring a novel cell-based, drug-delivery platform in which a therapeutic microbe is engineered to detect a specific pathogen and deliver antimicrobial protein fragments in the local pathogen environment in high concentrations. This research may have a broad impact on synthetic-biology solutions for biosecurity applications and antibiotic-resistant infections in both military and civilian healthcare environments.
Lee, T., et al. 2018. "Improved Expression of Host-Toxic Antimicrobial Peptides in Escherichia coli Using an Encapsulin Nanocompartment System." 2018 Synthetic Biology: Engineering, Evolution and Design (SEED) Conference, Scottsdale, AZ, June 2018. LLNL-POST-752026.
Lawrence Livermore National Laboratory • 7000 East Avenue • Livermore, CA 94550
Operated by Lawrence Livermore National Security, LLC, for the Department of Energy's National Nuclear Security Administration.